West Pharmaceutical Services, Inc. (NYSE:WST) Shares Purchased by RTD Financial Advisors Inc.

RTD Financial Advisors Inc. raised its holdings in West Pharmaceutical Services, Inc. (NYSE:WST) by 120.2% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 1,524 shares of the medical instruments supplier’s stock after acquiring an additional 832 shares during the quarter. RTD Financial Advisors Inc.’s holdings in West Pharmaceutical Services were worth $457,000 as of its most recent filing with the Securities and Exchange Commission.

Other large investors also recently made changes to their positions in the company. Pitcairn Co. raised its position in shares of West Pharmaceutical Services by 3.4% during the first quarter. Pitcairn Co. now owns 875 shares of the medical instruments supplier’s stock worth $346,000 after purchasing an additional 29 shares during the period. Clearbridge Investments LLC raised its holdings in West Pharmaceutical Services by 0.7% during the 1st quarter. Clearbridge Investments LLC now owns 4,495 shares of the medical instruments supplier’s stock worth $1,779,000 after buying an additional 31 shares during the period. Ballentine Partners LLC lifted its stake in West Pharmaceutical Services by 4.7% during the second quarter. Ballentine Partners LLC now owns 742 shares of the medical instruments supplier’s stock valued at $244,000 after buying an additional 33 shares in the last quarter. RFG Advisory LLC boosted its holdings in shares of West Pharmaceutical Services by 2.3% in the second quarter. RFG Advisory LLC now owns 1,499 shares of the medical instruments supplier’s stock worth $494,000 after buying an additional 34 shares during the period. Finally, Bleakley Financial Group LLC increased its position in shares of West Pharmaceutical Services by 1.9% in the first quarter. Bleakley Financial Group LLC now owns 2,174 shares of the medical instruments supplier’s stock worth $860,000 after acquiring an additional 41 shares in the last quarter. Institutional investors own 93.90% of the company’s stock.

West Pharmaceutical Services Trading Up 1.7 %

Shares of NYSE:WST traded up $5.43 during mid-day trading on Wednesday, hitting $328.90. The stock had a trading volume of 24,439 shares, compared to its average volume of 567,561. The company’s 50 day moving average is $302.32 and its 200-day moving average is $318.15. West Pharmaceutical Services, Inc. has a 12-month low of $265.00 and a 12-month high of $413.70. The company has a debt-to-equity ratio of 0.07, a quick ratio of 2.23 and a current ratio of 3.00. The company has a market cap of $23.82 billion, a PE ratio of 47.99, a P/E/G ratio of 23.71 and a beta of 1.00.

West Pharmaceutical Services (NYSE:WST) last released its earnings results on Thursday, October 24th. The medical instruments supplier reported $1.85 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.50 by $0.35. The company had revenue of $746.90 million during the quarter, compared to analyst estimates of $709.62 million. West Pharmaceutical Services had a return on equity of 18.41% and a net margin of 17.37%. The company’s revenue for the quarter was down .1% on a year-over-year basis. During the same quarter in the prior year, the company earned $2.16 earnings per share. On average, sell-side analysts predict that West Pharmaceutical Services, Inc. will post 6.69 EPS for the current year.

West Pharmaceutical Services Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, November 20th. Stockholders of record on Wednesday, November 13th will be issued a $0.21 dividend. This is an increase from West Pharmaceutical Services’s previous quarterly dividend of $0.20. The ex-dividend date is Wednesday, November 13th. This represents a $0.84 dividend on an annualized basis and a dividend yield of 0.26%. West Pharmaceutical Services’s dividend payout ratio is currently 11.87%.

Insider Transactions at West Pharmaceutical Services

In other West Pharmaceutical Services news, VP Charles Witherspoon sold 703 shares of the company’s stock in a transaction that occurred on Tuesday, October 29th. The shares were sold at an average price of $310.40, for a total value of $218,211.20. Following the transaction, the vice president now owns 1,253 shares in the company, valued at approximately $388,931.20. This represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. 0.53% of the stock is owned by insiders.

About West Pharmaceutical Services

West Pharmaceutical Services, Inc designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products.